Roche has opened the doors to its new center of excellence supply manufacturing facility in New Jersey, US.
The plant will process high potency compounds into medicines preclinical safety studies, as well as for Phase I and II trials.
Dosage forms produced at the 17,000 sq ft factory, in Nutley, include tablets, capsules, powders , suspensions and solutions.
“This is a vitally important milestone for the Nutley site as well as Pharmaceutical Research and Early Development at Roche,” Waseem Malick, VP of pharmaceutical & analytical R&D at Roche said.
“It enables continued support of our portfolio, and is another example of Roche’s commitment to Nutley as a major research center for Roche.”